首页> 外文OA文献 >A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

【2h】

A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

机译：24周的双盲安慰剂对照对轻度至中度阿尔茨海默病和抑郁症状的患者AMPA调节剂S47445的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Katy Bernard; Sylvie Gouttefangeas; Sylvie Bretin; Stéphanie Galtier; Philippe Robert; Vjera Holthoff‐Detto; Jeffrey Cummings; Maria Pueyo;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. [J] . Alvarez XA, Cacabelos R, Laredo M, European journal of neurology: the official journal of the European Federation of Neurological Societies . 2006,第1期

机译：在轻度至中度阿尔茨海默氏病患者中对三种剂量的脑溶素进行了为期24周，双盲，安慰剂对照的研究。
2. A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease [J] . Fujii A., Graf A., Homma A., Dementia and Geriatric Cognitive Disorders Extra . 2011,第1期

机译：一项为期24周，随机，双盲，安慰剂对照的研究，旨在评估Rivastigmine贴剂对日本阿尔茨海默氏病患者的疗效，安全性和耐受性
3. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study [J] . Florian Hana, Meier Andreas, Gauthier Serge, Journal of Alzheimer's disease: JAD . 2016,第4期

机译：ABT-126对轻度至中度阿尔茨海默氏病患者乙酰胆碱酯酶抑制剂稳定剂量的疗效和安全性：一项随机，双盲，安慰剂对照的研究
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms [O] . Katy Bernard, Sylvie Gouttefangeas, Sylvie Bretin, 2015

机译：24周双盲安慰剂对照研究，研究AMPA调节剂S47445在轻度至中度阿尔茨海默氏病和抑郁症状患者中的疗效和安全性
7. The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial [O] . Christopher L.H. Chen, Purabi Reang Sharma, Boon Yeow Tan, 2019

机译：Lzheimer的疾病与Ne Uroaid（Athene）的研究方案的脱脂剂：评估神经外套II（MLC901）在胆碱酯酶抑制剂或Memantine-A随机的双盲患者稳定的患者中神经外套II（MLC901）的安全性和有效性安慰剂对照试验

A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

著录项

相似文献

相关主题

期刊订阅